Dr Emma Thomas-Jones
@emmatj.bsky.social
Principal Research Fellow and Deputy Director for Infections, Inflammation and Immunity Trials at the Centre for Trials Research (CTR) at Cardiff University.
Personal views.
Personal views.
Reposted by Dr Emma Thomas-Jones
Antimicrobial resistance (AMR) is a major threat to human health.
Bur it's GROSSLY under reported
This study showed 4% of ALL deaths at a major London hospital were actually caused AMR but NONE were on the death certificate as cause of death.
Bur it's GROSSLY under reported
This study showed 4% of ALL deaths at a major London hospital were actually caused AMR but NONE were on the death certificate as cause of death.
#AMR is a risk to antibiotic failure & death, but if this happens, do we record it on death certificates? Our centre data = NO!
👉In 1 year, 4% of deaths were AMR-attributed & NONE were recorded on death certificates!👈
Need to quantify this better to increase awareness! #IDSky @jac-amr.bsky.social
👉In 1 year, 4% of deaths were AMR-attributed & NONE were recorded on death certificates!👈
Need to quantify this better to increase awareness! #IDSky @jac-amr.bsky.social
Antimicrobial resistance–attributable mortality: a patient-level analysis
AbstractBackground. The impact of antimicrobial resistance (AMR) on death at the patient level is challenging to estimate. We aimed to characterize AMR-att
academic.oup.com
January 9, 2025 at 8:21 AM
Antimicrobial resistance (AMR) is a major threat to human health.
Bur it's GROSSLY under reported
This study showed 4% of ALL deaths at a major London hospital were actually caused AMR but NONE were on the death certificate as cause of death.
Bur it's GROSSLY under reported
This study showed 4% of ALL deaths at a major London hospital were actually caused AMR but NONE were on the death certificate as cause of death.
Reposted by Dr Emma Thomas-Jones
11/ Pragmatic designs allow real-world evaluation of clinical effectiveness, but not implementation processes, which would allow scale-up of the intervention if found to be effective. i.e. is the intervention generalisable? We need more effectiveness-implementation hybrid designs.
January 9, 2025 at 6:57 AM
11/ Pragmatic designs allow real-world evaluation of clinical effectiveness, but not implementation processes, which would allow scale-up of the intervention if found to be effective. i.e. is the intervention generalisable? We need more effectiveness-implementation hybrid designs.
Reposted by Dr Emma Thomas-Jones
1/ Delighted to report the results of the Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH) trial in @LancetChildAdol
authors.elsevier.com/sd/article/S...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
authors.elsevier.com
January 9, 2025 at 6:46 AM
1/ Delighted to report the results of the Procalcitonin-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection in the UK (BATCH) trial in @LancetChildAdol
authors.elsevier.com/sd/article/S...